Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sat Kartar Life Ltd

NSE: SATKARTAR · Pharmaceuticals & Biotechnology · 49 announcements

Sat Kartar Life Ltd news stories on ALFA NewsRead the news →
Share price
₹159.70
Market cap
₹252.2 Cr
Revenue (annual)
₹200.7 Cr
Net profit (annual)
₹17.10 Cr
P/E (TTM)
14.8×Sector 47.3×
Promoter holding
63.62%
FII holding
0.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

00:25 IST NSE
Fund Raise

Sat Kartar Life Fund Raise of ₹46.36 Cr

Sat Kartar Life allotted 26,95,200 convertible warrants at ₹172 each via preferential issue, raising ₹46.36 Crore. The company received 25% upfront subscription money from fourteen investors.

Value
₹46.36 Cr
00:17 IST NSE
Fund Raise

Sat Kartar Life Fund Raise of ₹0.87 Cr

Sat Kartar Life Limited allotted 50,400 equity shares via preferential issue to Viney Growth Fund. The company raised ₹0.87 Crore to strengthen its overall capital base.

Value
₹0.87 Cr
23:38 IST NSE
Fund Raise

Sat Kartar Life Fund Raise of ₹0.87 Cr

Sat Kartar Life allotted 50,400 equity shares to Viney Growth Fund via a preferential issue. The company raised ₹0.87 Crore to strengthen its financial position.

Value
₹0.87 Cr
23:41 IST NSE
Fund Raise

Sat Kartar Life Fund Raise of ₹1.16 Cr

Sat Kartar Life Limited allotted 26.95 lakh convertible warrants via preferential issue. The company raised ₹1.16 Crore as upfront subscription money to strengthen its capital base.

Value
₹1.16 Cr
15:50 IST NSE
Fund Raise

Sat Kartar Life Fund Raise of ₹33.8 Cr

Sat Kartar Life Limited submitted its Monitoring Agency Report for the half-year ended March 31, 2026. The report, issued by CARE Ratings, monitors the utilization of ₹33.80 Crore raised through its IPO. No deviations from the stated objects were reported during the period.

Value
₹33.80 Cr
17:56 IST NSE
Fund Raise

Sat Kartar Life Fund Raise of ₹47.72 Cr

Sat Kartar Life Limited issued a corrigendum for a proposed preferential issue of 27,74,400 convertible warrants at ₹172 each, totaling ₹47.72 Crore. The funds will be utilized for healthcare expansion, strategic acquisitions, and technology branding. The warrants are convertible into equity shares within 18 months.

Value
₹47.72 Cr
Execution
18 months